Seattle Cancer Care Alliance opens Acute Clinical Evaluation Clinic

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Seattle Cancer Care Alliance opened an Acute Clinical Evaluation clinic. The three bed ACE clinic at SCCA’s South Lake Union campus serves individuals receiving cancer care at SCCA who experience cancer- and treatment-related pain and symptoms that surpass their ability to manage at home.

Originally planned for summer 2020, the ACE clinic opened ahead of schedule so that cancer patients would not have to visit an urgent care or emergency room for cancer-treatment related issues, especially important during the COVID-19 pandemic.

“We are committed to advancing the standard of cancer care, regionally and beyond, and the ACE clinic is a reflection of that commitment,” said Nancy Davidson, president and executive director of SCCA. “At SCCA, we provide comprehensive care, and the ACE clinic provides our patients with access to care from our highly trained, compassionate staff, specifically for their treatment-related pain and other symptoms.”

The ACE clinic is staffed by an oncology advanced practice provider and registered nurses specializing in cancer care. SCCA providers can refer patients to the clinic who need medical oncology care for pain and symptom management for issues including but not limited to gastrointestinal discomfort, fever/chills, dehydration, dizziness/lightheadedness, urinary tract infections, swallowing difficulties, swelling and skin conditions/rashes.

The ACE clinic does not provide emergency care and is limited to patients who are already receiving treatment from SCCA providers.

Table of Contents

YOU MAY BE INTERESTED IN

Just consider for a minute if this was the first year of running your lab, if you were on the job market as a physician or scientist right now, if you were a resident contemplating a career in cancer research after fellowship, if you were a graduate student or postdoc, if you were an undergraduate or a technician who was looking toward graduate school.
The immune system can be a powerful tool to control cancer. Immune cells within our body detect cancer cells and release payloads that kill them. Transformative science in the last decade has led to the development of therapies that enhance the ability of our immune cells to carry out this function. These therapies, including checkpoint blockade and CAR-T cells, have been lifesaving for many patients that before had untreatable cancer. But, sadly, a majority of patients with advanced solid tumors still succumb to their disease. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login